Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extension.
Cooper N, Bussel JB, Kaźmierczak M, Miyakawa Y, Cluck S, Lledó García R, Haier B, Lavrov A, Singh P, Snipes R, Kuter DJ. Cooper N, et al. Among authors: kazmierczak m. Br J Haematol. 2024 Nov 18. doi: 10.1111/bjh.19858. Online ahead of print. Br J Haematol. 2024. PMID: 39552477
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies.
Röth A, Fu R, He G, Alzahrani H, Chou SC, Hicheri Y, Kaźmierczak M, Recova VL, Uchiyama M, Vladareanu AM, Beveridge L, Buatois S, Buri M, Compagno N, Shi D, Balachandran N, Sreckovic S, Scheinberg P. Röth A, et al. Among authors: kazmierczak m. Eur J Haematol. 2024 Nov 13. doi: 10.1111/ejh.14339. Online ahead of print. Eur J Haematol. 2024. PMID: 39535306
Trust in government moderates the association between fear of COVID-19 as well as empathic concern and preventive behaviour.
Karakulak A, Tepe B, Dimitrova R, Abdelrahman M, Akaliyski P, Alaseel R, Alkamali YA, Amin A, Lizarzaburu Aguinaga DA, Andres A, Aruta JJBR, Assiotis M, Avanesyan H, Ayub N, Bacikova-Sleskova M, Baikanova R, Bakkar B, Bartoluci S, Benitez D, Bodnar I, Bolatov A, Borchet J, Bosnar K, Broche-Pérez Y, Buzea C, Cassibba R, Carbonell MM, Chen BB, Dimitrovska GR, Công Doanh D, Dominguez Espinosa ADC, Edine WG, Ferenczi N, Fernández-Morales R, Gaete J, Gan Y, Giolo S, Giordani RCF, Friehs MT, Gindi S, Gjoneska B, Godoy JC, Del Pilar Grazioso M, Hancheva C, Hapunda G, Hihara S, Husain MS, Islam MS, Janovská A, Javakhishvili N, Jovanović V, Kabir RS, Abdul Kadir NB, Karl J, Katović D, Kauyzbay Z, Kawashima TD, Kazmierczak M, Khanna R, Khosla M, Klicperová-Baker M, Kozina A, Krauss SE, Landabur R, Lefringhausen K, Lewandowska-Walter A, Liang YH, Makashvili A, Malik S, Manrique-Millones D, Mastrotheodoros S, McGrath B, Mechili EA, Mejía M, Mhizha S, Michalek-Kwiecien J, Miconi D, Mohsen F, Moreta-Herrera R, Muhl C, Muradyan M, Musso P, Naterer A, Nemat A, Neto F, Neto J, Palacio LMA, Okati-Aliabad H, Orellana CI, Orellana LM, Mishra SK, Park J, Pavlova I, Peralta E, Petrytsa P, Pišot … See abstract for full author list ➔ Karakulak A, et al. Among authors: kazmierczak m. Commun Psychol. 2023 Dec 15;1(1):43. doi: 10.1038/s44271-023-00046-5. Commun Psychol. 2023. PMID: 39242865 Free PMC article.
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.
Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, O'Brien SM, Tam CS, Qiu L, Zhou K, Simkovic M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Salmi T, Wang MD, Fu L, Li J, Wu K, Cohen A, Shadman M. Brown JR, et al. Among authors: kazmierczak m. Future Oncol. 2024 Apr;20(12):717-726. doi: 10.2217/fon-2023-0849. Epub 2023 Dec 13. Future Oncol. 2024. PMID: 39132937
183 results